Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Longeveron ( (LGVN) ) just unveiled an update.
On November 7, 2025, Longeveron Inc. announced the immediate resignation of Mr. Khoso Baluch and Ms. Neha Motwani from its Board of Directors. Their departures were not due to any disagreements with the company’s operations, policies, or management, suggesting a smooth transition without internal conflict.
The most recent analyst rating on (LGVN) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on Longeveron stock, see the LGVN Stock Forecast page.
Spark’s Take on LGVN Stock
According to Spark, TipRanks’ AI Analyst, LGVN is a Neutral.
Longeveron’s overall stock score reflects significant financial and operational challenges, with declining revenues and negative profitability being the most impactful factors. Technical analysis indicates bearish momentum, and valuation metrics highlight substantial risk. While the earnings call provided some positive developments in clinical trials, financial risks remain a major concern.
To see Spark’s full report on LGVN stock, click here.
More about Longeveron
Average Trading Volume: 794,246
Technical Sentiment Signal: Sell
Current Market Cap: $15.82M
See more insights into LGVN stock on TipRanks’ Stock Analysis page.